GlassScriptPhysician profile
Emily M Greene
NPI 1700110475
$1,220.99
in general payments reported to CMS, 2019-2025
18 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $174 · 2022: $107 · 2023: $276 · 2024: $414 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $940.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $365.19 | 2022-2025 | |
| Abbvie INC. | $258.61 | 2023-2025 | |
| Astellas Pharma US INC | $147.31 | 2021-2024 | Xtandi, Myrbetriq |
| Urogen Pharma, INC. | $58.57 | 2024 | |
| Sumitomo Pharma America, INC. | $51.68 | 2024-2025 | Gemtesa |
| Progenics Pharmaceuticals, INC. | $51.16 | 2023-2025 | Pylarify |
| Urovant Sciences INC | $44.08 | 2021-2022 | |
| Lilly USA, LLC | $41.95 | 2023 | Mounjaro |
| Merck Sharp & Dohme LLC | $31.39 | 2025 | Zerbaxa |
| Laborie Medical Technologies Corp. | $27.94 | 2022 | |
| Endo USA, INC. | $22.96 | 2025 | Xiaflex, Aveed |
| Bayer Healthcare Pharmaceuticals INC. | $20.72 | 2021 | |
| Medtronic, INC. | $20.17 | 2024 | V-Loc 180 |
| Smith+Nephew, INC. | $18.25 | 2021 | |
| Rochester Medical Corporation | $17.58 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $16.25 | 2024 | Adstiladrin |
| Myriad Genetic Laboratories, INC. | $14.48 | 2021 | |
| Axonics, INC. | $12.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Greene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.